Given that p300 is importantly involved in the development of renal inflammation in diabetic kidney disease [24,25,26], our findings suggest that inhibition of p300 by garcinol is responsible for the suppression of cisplatin-induced inflammatory responses, presumably through inhibiting cytokine production and immune cell accumulation. Here, EP300 is linked to inflammatory response.